• 1. Cobalt(ii)-catalyzed chelation-assisted C–H iodination of aromatic amides with I2
  Yadagiri Kommagalla,Ken Yamazaki,Takuma Yamaguchi,Naoto Chatani Chem. Commun. 2018 54 1359
• 2. 88. The Skraup reaction with m-substituted anilines
  L. Bradford,T. J. Elliott,F. M. Rowe J. Chem. Soc. 1947 437
• 3. Co-oligomerization of diphenylketene and ethylene promoted by (η 5-cyclopentadienyl)bis(ethylene)cobalt(I): synthesis and X-ray structure of a heterocycle containing cobalt(III)
  Sandro Gambarotta,Sergio Stella,Carlo Floriani,Angiola Chiesi-Villa,Carlo Guastini 5-cyclopentadienyl)bis(ethylene)cobalt(I): synthesis and X-ray structure of a heterocycle containing cobalt(III). Sandro Gambarotta Sergio Stella Carlo Floriani Angiola Chiesi-Villa Carlo Guastini J. Chem. Soc. Dalton Trans. 1987 1789
• 4. Photoexcited Pd(ii) auxiliaries enable light-induced control in C(sp3)–H bond functionalisation
  Milena L. Czyz,Geethika K. Weragoda,Tyra H. Horngren,Timothy U. Connell,Daniel Gomez,Richard A. J. O'Hair,Anastasios Polyzos Chem. Sci. 2020 11 2455
• 5. Manganese N,N,N-pincer complex-catalyzed epoxidation of unactivated aliphatic olefins
  Dennis Verspeek,Sebastian Ahrens,Anke Spannenberg,Xiaodong Wen,Yong Yang,Yong-Wang Li,Kathrin Junge,Matthias Beller Catal. Sci. Technol. 2022 12 7341

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Chloroquinolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines Chloroquinolines

Professional Introduction to 5-Chloroquinoline (CAS No. 635-27-8)

5-Chloroquinoline, with the chemical formula C₉H₅ClN₂, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical chemistry and medicinal research. Its CAS number, CAS No. 635-27-8, uniquely identifies it in scientific literature and industrial applications. This compound, a derivative of quinoline, exhibits a broad spectrum of biological activities, making it a valuable scaffold for the development of novel therapeutic agents.

The chemical structure of 5-Chloroquinoline features a chlorinated quinoline ring, which enhances its reactivity and biological potency. The chlorine atom at the 5-position introduces electrophilic characteristics, facilitating various chemical modifications and functionalizations. These properties have made it a popular intermediate in synthetic chemistry, particularly in the synthesis of more complex molecules with targeted pharmacological effects.

In recent years, 5-Chloroquinoline has been extensively studied for its potential applications in addressing various diseases. One of the most notable areas of research has been its role in antimalarial therapy. Quinoline derivatives have a long history in combating malaria, and 5-Chloroquinoline has been investigated as a possible candidate to overcome resistance issues associated with existing antimalarial drugs. Preliminary studies suggest that modifications to the quinoline scaffold, such as chlorination at the 5-position, can enhance efficacy against drug-resistant strains of Plasmodium.

Beyond antimalarial applications, 5-Chloroquinoline has shown promise in other therapeutic domains. Its ability to interact with biological targets such as enzymes and receptors has led to research into its potential as an antimicrobial agent. Furthermore, its structural similarity to other bioactive compounds makes it a valuable building block for drug discovery programs aimed at developing treatments for infectious diseases and inflammatory conditions.

The synthesis of 5-Chloroquinoline typically involves the chlorination of quinoline or related precursors. Advanced synthetic methodologies have been developed to improve yield and purity, ensuring that the final product meets the stringent requirements of pharmaceutical applications. These methods often incorporate catalytic processes and green chemistry principles to minimize environmental impact while maximizing efficiency.

The pharmacological profile of 5-Chloroquinoline is shaped by its interaction with various biological systems. Research has highlighted its potential as a kinase inhibitor, with implications for cancer therapy. By targeting specific kinases involved in cell proliferation and survival, 5-Chloroquinoline derivatives may offer a novel approach to treating certain types of cancer. Additionally, its effects on immune modulation have sparked interest in its use as an immunomodulatory agent.

In academic research, the study of 5-Chloroquinoline continues to evolve with advancements in computational chemistry and high-throughput screening techniques. These tools have enabled researchers to rapidly evaluate the biological activity of numerous derivatives, accelerating the discovery process. The integration of machine learning algorithms has further enhanced the ability to predict novel drug candidates based on structural features like those found in CAS No. 635-27-8.

The industrial production of 5-Chloroquinoline adheres to rigorous quality control measures to ensure consistency and safety. Manufacturers employ state-of-the-art purification techniques to isolate the compound from impurities, meeting regulatory standards for pharmaceutical use. This attention to detail is crucial for ensuring that therapeutic agents derived from this compound are both effective and safe for patient consumption.

The future prospects for 5-Chloroquinoline are promising, with ongoing research exploring new applications and formulations. Innovations in drug delivery systems may enhance its bioavailability and therapeutic efficacy. Collaborative efforts between academia and industry are essential to translate laboratory findings into clinical reality, bringing new treatments to patients worldwide.

In conclusion, CAS No. 635-27-8, or more accurately referred to as 5-Chloroquinoline, represents a cornerstone in modern pharmaceutical research. Its unique chemical properties and broad biological activity make it an indispensable tool for developing innovative therapies across multiple disease areas. As scientific understanding continues to advance, the potential applications of this remarkable compound are likely to expand even further.

• 366495-92-3(4,7-Dichloroquinoline-15N)
• 4203-18-3(4,6-Dichloroquinoline)
• 12365-92-3(4,7-Dichloroquinolinium tribromide)
• 1019-14-3(Acridine, 2,9-dichloro-)
• 86-98-6(4,7-Dichloroquinoline)
• 62383-19-1(Acridine, 2,6,9-trichloro-)
• 35547-70-7(6,9-Dichloroacridine)
• 1207-69-8(9-Chloroacridine)
• 611-35-8(4-Chloroquinoline)
• 21617-18-5(4,5-Dichloroquinoline)